Scientific Background
This blend combines two growth-hormone–releasing peptides: CJC-1295 (No DAC), which
interacts with GHRH receptors, and Ipamorelin, a selective ghrelin-receptor agonist. The result is
a physiologic dual-pathway GH-axis support tool frequently used in recovery, repair, and
wellness research.
Mechanism of Action (Informational Only)

• CJC-1295 stimulates GHRH receptor signaling
• Ipamorelin activates ghrelin-receptor pathways
• Synergistic GH release stimulation
• Downstream influence on cellular repair processes

Potential Functional Benefits

• Research interest in recovery after training
• Supports natural GH pulsatility
• May complement body-composition studies
• Supports sleep and cellular repair signaling in models

Vial Contents

• CJC-1295 No DAC 5mg
• Ipamorelin 5mg

Notes
For research and educational purposes only.